When.com Web Search

  1. Ads

    related to: do statins reduce cardiovascular mortality rate

Search results

  1. Results From The WOW.Com Content Network
  2. Statins may lower risk for heart disease and death, even in ...

    www.aol.com/lifestyle/statins-may-lower-risk...

    Statins reduce cardiovascular death risk in older adults. ... Recent estimates show that in 2019, the heart disease-related mortality rate among people ages 60 to 80 was 77–80%, and 85% for ...

  3. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    Mortality and adverse cardiovascular events were reduced in statin groups. [42] Older adults who receive statin therapy at time of discharge from the hospital after an inpatient stay have been studied. People with cardiac ischemia not previously on statins at the time of admission have a lower risk of major cardiac adverse events and hospital ...

  4. Fewer people may need statins to prevent heart disease, new ...

    www.aol.com/news/fewer-people-may-statins...

    In other words, as many as 4 million people in the U.S. who currently take statins for primary prevention — meaning they have not had a cardiovascular event such as a stroke or heart attack ...

  5. JUPITER trial - Wikipedia

    en.wikipedia.org/wiki/JUPITER_trial

    The trial analyzed 17,802 patients without evidence of heart disease but with high CRP levels. In 2008, results presented at the American Heart Association meeting and published in the New England Journal of Medicine (NEJM) found that patients with low-to-normal LDL cholesterol receiving rosuvastatin had a lower rate of major cardiovascular events.

  6. 17 million US adults may no longer receive statin therapy for ...

    www.aol.com/lifestyle/17-million-us-adults-may...

    These guidelines recommend statin therapy for adults between forty and seventy-five who have diabetes, high cholesterol levels, or an estimated 10-year atherosclerotic cardiovascular disease risk ...

  7. Cardiovascular disease - Wikipedia

    en.wikipedia.org/wiki/Cardiovascular_disease

    Niacin, fibrates and CETP Inhibitors, while they may increase HDL cholesterol do not affect the risk of cardiovascular disease in those who are already on statins. [167] Fibrates lower the risk of cardiovascular and coronary events, but there is no evidence to suggest that they reduce all-cause mortality. [168]